Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-07.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ferring Production Inc. | 7 Mar 2025 | Biologics | On file |
| Lonza Houston, Inc | 2 Feb 2024 | Biologics | |
| Minaris Regenerative Medicine, LLC | 25 Sep 2023 | Biologics | On file |
| Kite Pharma, Inc. | 4 Mar 2022 | Biologics |
Sites inspected
Ferring Production Inc.Parsippany, United States1 insp.
Lonza Houston, IncHouston, United States1 insp.
Minaris Regenerative Medicine, LLCAllendale, United States1 insp.
Kite Pharma, Inc.Frederick, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Graeme E Price2 shared
Shen Lin1 shared
Zhili Xu1 shared
Holly Brevig1 shared
Jogy George1 shared
Pankaj K Mandal1 shared
Nirjal Bhattarai1 shared
Rabia Ballica1 shared
Alan G Baer1 shared
Christine Harman1 shared
Full investigator report
Get the verbatim findings behind Phillip C Thai's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site